NASDAQ: NGEN
Nervgen Pharma Corp Stock Ownership - Who owns Nervgen Pharma?

Insider buying vs selling

Have Nervgen Pharma Corp insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NGEN insiders and whales buy or sell their stock.

NGEN Shareholders

What type of owners hold Nervgen Pharma Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Empery0.00%4,000$6.84kInstitution
Empery Asset Management LP0.00%4,000$6.84kInstitution
Rocspr0.00%1,208$2.07kInstitution
Rock Springs Capital Management LP0.00%1,208$2.07kInstitution
Dafnac0.00%1,050$1.80kInstitution
Dafna Capital Management LLC0.00%1,050$1.80kInstitution
Ghisallo Capital Management LLC0.00%1,000$1.71kInstitution
Ghisal0.00%1,000$1.71kInstitution
Armist0.00%678$1.16kInstitution
Armistice Capital LLC0.00%678$1.16kInstitution

1 of 3

NGEN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NGEN0.01%0.00%
CUE0.02%92.06%Net BuyingNet Selling
ACOG0.05%33.64%Net BuyingNet Buying
MDWD0.05%0.20%Net BuyingNet Buying
PLX0.01%99.99%Net Buying

Nervgen Pharma Stock Ownership FAQ

Who owns Nervgen Pharma?

Nervgen Pharma (NASDAQ: NGEN) is owned by 0.01% institutional shareholders, 0.00% Nervgen Pharma insiders, and 99.99% retail investors. Empery is the largest individual Nervgen Pharma shareholder, owning 4000.00 shares representing 0.00% of the company. Empery's Nervgen Pharma shares are currently valued at $6.84k.

If you're new to stock investing, here's how to buy Nervgen Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.